Food and Drug
Administration
Nonprescription
Drugs Advisory Committee
September 25, 2006
Slides
FDA Slide Presentations
Leonard-Segal, MD, Director
of Nonprescription Clinical Evaluation, FDA. Label Comprehension,
Self-Selection & Actual Use Studies: Issues & Challenges
(ppt)
(pdf)
Terry C. Davis, PhD, Louisiana State University
& Ruth Parker, MD, Emory University. Health Literacy,
(ppt)
(pdf)
Saul Shiffman, PhD, University of Pittsburg.
Behavior Studies Supporting Rx-to-OTC Switches (ppt) (pdf
)
Ruth S. Day, PhD, Duke University. Cognitive
Accessibility (ppt) (pdf )
Ralph D’Agostino, PhD, University. Consumer
Behavior Studies: Statistical Issues (ppt) (pdf)
Alastair Wood, MD, Managing Dir)ect)or, Symphony Capital LLC,
New York, NY. Complexities of the Rx-to-OTC Switch (
ppt) (
pdf)
Public Hearing Presentations
(
ppt)
(
pdf)
Douglas Ws. Bierer, PhD, Consumer Healthcare
Products Association. Industry Recommendations on Evaluating
OTC Consumer Behavior (ppt) (pdf)
Questions (
pdf)
(
ppt)
(
htm)
Up
| AC Home Page